BioAtla BCAB
OTC BCAB
$1.50 -0.10 (-6.25%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioAtla (BCAB) Total Debt (2020 - 2021)

Updated

BioAtla's Total Debt was $682,000 in Q2 2021, unchanged from the prior quarter.

Analysis

BioAtla (BCAB) Total Debt (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 49.04 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 70.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -111.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 BioAtla 2.49 Mn 2.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 682,000.00
Mar 31, 2021 682,000.00
Dec 31, 2020 682,000.00
API Access

BioAtla Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=BCAB&period=max&api_key=YOUR_API_KEY